Evidence map›Paper›PMID 41064600›Full record

ArticleCase reports in endocrinology2025

Severe Phenotype of De Novo TSHR Activating Pathogenic Variants.

Anna C Torrey, Michael Zuccaro, Jonathan B Steinman, Alex Guo, Helen Ellsworth, Michael A Fremed, Vidhu V Thaker

Abstract readCase Reports
In one paragraph

Article in Case reports in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna C TorreyVagelos College of Physicians and Surgeons, Columbia University, New York 10032, New York, USA.
Michael ZuccaroDivision of Genetics and Genomics, Boston Children's Hospital, Boston 02115, Massachusetts, USA.
Jonathan B SteinmanDivision of Pediatric Endocrinology, Department of Pediatrics, Columbia University Irving Medical Center, New York 10032, New York, USA.
Alex GuoDivision of Molecular Genetics, Department of Pediatrics, Columbia University Irving Medical Center, New York 10032, New York, USA.
Helen EllsworthDepartment of Pathology, Columbia University Irving Medical Center, New York 10032, New York, USA.
Michael A FremedDivision of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, New York 10032, New York, USA.
Vidhu V ThakerVagelos College of Physicians and Surgeons, Columbia University, New York 10032, New York, USA.ORCID https://orcid.org/0000-0002-3537-2782

Funding

Diabetes-Docs: Physician-Scientist Career Development Program (DiabDocs)K12DK133995 · NIDDK · STANFORD UNIVERSITY · PI LINDA A DIMEGLIO, David Matthew Maahs · 2022 to 2026
$16.0M
NIDDK NIH HHS K12 DK133995
6 · The paper itself

Abstract

Context: The phenotypic spectrum of thyroid-stimulating hormone (TSH) receptor (TSHR) pathogenic variants is broad. Germline variants causing constitutive TSHR activation in the absence of TSH result in familial nonautoimmune hyperthyroidism (FNAH) or sporadic nonautoimmune hyperthyroidism (SNAH). This hyperthyroid state, if present in utero or early childhood, can impact multisystem development. The consequences of severe early-onset hyperthyroidism have not been well described. Clinical Cases: Here, we report two unrelated individuals, each with a distinct monoallelic de novo TSHR pathogenic variant leading to severe congenital hyperthyroidism that required multistep thyroidectomies. Both patients had thyroid hypertrophy and vulnerable anatomic positioning of recurrent laryngeal nerves (RLNs), complicating surgical management. Case 1 is a 4-year-old boy with craniosynostosis and mitral valve dysplasia with SNAH caused by a heterozygous TSHR variant c.1515C >A; p.S505R. Hyperthyroidism was detected with thyroid storm at 17 months of age. Case 2 is a 9-year-old girl with SNAH and craniosynostosis from a novel heterozygous TSHR variant c.1897G >C; p.D633H identified in the neonatal period. Conclusion: The severe hyperthyroidism and complex course seen in these individuals contrast with previously reported cases. These cases highlight the wide phenotypic spectrum of TSHR activating variants and the persistent clinical sequelae of SNAH.

Indexed as

aberrant recurrent laryngeal nervecraniosynostosishyperthyroidismTSHR activating variants

Identifiers

PMID41064600
PMCPMC12504001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.